Literature DB >> 21547529

Male hormonal contraception: potential risks and benefits.

Niloufar Ilani1, Ronald S Swerdloff, Christina Wang.   

Abstract

An effective, safe, reversible, and acceptable method of contraception is an important component of reproductive health and provides the opportunity of shared responsibility for family planning for both partners. Female hormonal contraceptives have been proven to be safe, reversible, available and widely acceptable by different populations. In contrast, male hormonal contraception, despite significant progress showing contraceptive efficacy comparable to female hormonal methods during last three decades, has not yet led to an approved product. Safety of a pharmaceutical product is an appropriate concern but the majority of male hormonal contraceptive clinical trials have not reported significant short term safety concerns. While the absence of serious adverse effects is encouraging, the studies have been designed for efficacy endpoints not long term safety. In this review we summarize potential risks and benefits of putative male hormonal contraceptives on reproductive and non-reproductive organs. While the review covers what we believe will be the likely class of drugs used for male hormonal contraception a true assessment of long term risks and benefits cannot be achieved without an available product.

Mesh:

Substances:

Year:  2011        PMID: 21547529     DOI: 10.1007/s11154-011-9183-3

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  108 in total

Review 1.  Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive.

Authors:  Robert I McLachlan; Liza O'Donnell; Sarah J Meachem; Peter G Stanton; KretserDavidM de; Kryiakos Pratis; David M Robertson
Journal:  J Androl       Date:  2002 Mar-Apr

2.  Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy.

Authors:  Amanda Jones; Dong-Jin Hwang; Ramesh Narayanan; Duane D Miller; James T Dalton
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

3.  Dihydrotestosterone: hormone or autocrine--paracrine signal?

Authors:  Ronald S Swerdloff; Christina Wang
Journal:  Ann Intern Med       Date:  2010-11-16       Impact factor: 25.391

4.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

5.  Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.

Authors:  Stephanie T Page; Daniel W Lin; Elahe A Mostaghel; Brett T Marck; Jonathan L Wright; Jennifer Wu; John K Amory; Peter S Nelson; Alvin M Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

Review 6.  Androgens and cardiovascular disease.

Authors:  Bu B Yeap
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

7.  A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.

Authors:  Yi-Qun Gu; Xing-Hai Wang; Dwo Xu; Lin Peng; Li-Fa Cheng; Ming-Kong Huang; Zhen-Jia Huang; Gui-Yuan Zhang
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

8.  The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

Authors:  Chris J Malkin; Peter J Pugh; Richard D Jones; Dheeraj Kapoor; Kevin S Channer; T Hugh Jones
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

Review 9.  Advances in male contraception.

Authors:  Stephanie T Page; John K Amory; William J Bremner
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

10.  A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.

Authors:  Sigrid von Eckardstein; Gabriela Noe; Vivian Brache; Eberhard Nieschlag; Horacio Croxatto; Francisco Alvarez; Alfred Moo-Young; Irving Sivin; Narender Kumar; Margaret Small; Kalyan Sundaram
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

View more
  9 in total

Review 1.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

2.  Male contraception: Where do we go from here?

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Spermatogenesis       Date:  2011-10-01

Review 3.  Continuing the search for a hormonal male contraceptive.

Authors:  Fiona Yuen; Brian T Nguyen; Ronald S Swerdloff; Christina Wang
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-02-19       Impact factor: 5.237

Review 4.  Male hormonal contraception: looking back and moving forward.

Authors:  M Y Roth; S T Page; W J Bremner
Journal:  Andrology       Date:  2015-10-09       Impact factor: 3.842

Review 5.  Male fertility and skin diseases.

Authors:  M Badawy Abdel-Naser; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 9.306

6.  The preparation and application of N-terminal 57 amino acid protein of the follicle-stimulating hormone receptor as a candidate male contraceptive vaccine.

Authors:  Cheng Xu; Ying-Chun Li; Hua Yang; Yan Long; Min-Jian Chen; Yu-Feng Qin; Yan-Kai Xia; Ling Song; Ai-Hua Gu; Xin-Ru Wang
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

Review 7.  Advances in male hormonal contraception.

Authors:  Antonietta Costantino; Giulia Gava; Marta Berra; Cristina Meriggiola Maria
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

8.  Are men ready to use thermal male contraception? Acceptability in two French populations: New fathers and new providers.

Authors:  Marie Amouroux; Roger Mieusset; Raoul Desbriere; Pierre Opinel; Gilles Karsenty; Marine Paci; Sara Fernandes; Blandine Courbiere; Jeanne Perrin
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

Review 9.  The future of male contraception: a fertile ground.

Authors:  Iyad Khourdaji; Jacqueline Zillioux; Kevin Eisenfrats; Daniel Foley; Ryan Smith
Journal:  Transl Androl Urol       Date:  2018-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.